
Strategic Market Entry Plan for a Global Pharmaceutical Company
BACKGROUND & OBJECTIVE
A leading global pharmaceutical company sought to develop a strategic market entry plan by conducting a Healthcare Landscape Assessment. The objective was to assess the market structure, access processes, and key stakeholders within the targeted therapeutic areas. The engagement focused on defining a strategy aligned with “Where to play,” “How to play,” and “How to Succeed”, ensuring a well-informed and data-driven approach to market penetration.
PROJECT APPROACH
The project began with an overview of market drivers and structure, identifying key stakeholders and regulatory considerations. A comprehensive stakeholder mapping was conducted, defining potential public and private sector players for interviews and data collection. A market opportunity assessment outlined key care delivery channels, major therapy centers, market potential, competitor landscape, policy gaps, and other influencing factors. Based on these insights, the team developed key strategic recommendations for market entry, ensuring alignment with industry best practices and business objectives.
OUR METHODOLOGY
A structured research methodology was applied, leveraging primary data collection through expert interviews and surveys, combined with secondary research to validate findings. The Landscape Assessment Framework was utilized to analyze key market trends, competitor positioning, and regulatory conditions. Stakeholder insights were gathered through expert discussions and workshop facilitation, ensuring that all perspectives were considered. The approach culminated in the development of a strategic roadmap detailing the optimal channels and processes for product distribution and sales.
THE RESULTS
The project successfully provided the client with a comprehensive understanding of the market landscape, including public and private sector stakeholders and key decision-makers. A Secondary Research and Interview Plan was developed, ensuring a structured data collection process. The engagement also provided key data on market structure and drivers, supporting data-driven decision-making. A strategic roadmap for market entry was delivered, outlining the best processes for distribution and sales. Finally, a workshop was conducted to present the findings and align stakeholders on the next steps.